Literature DB >> 2044224

Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis.

N Sheron1, G Bird, J Goka, G Alexander, R Williams.   

Abstract

Recent studies in alcoholic hepatitis have proposed a role for the cytokine tumour necrosis factor-alpha (TNF-alpha) a mediator of endotoxic shock in sepsis. In this study plasma levels of the closely related cytokine interleukin-6 (IL-6) were assayed in 96 samples from 58 patients with severe alcoholic hepatitis, and 69 patients in control groups (21 normal, 10 alcoholic without liver disease, 10 inactive alcoholic cirrhosis, 18 chronic liver disease, 10 chronic renal failure). Plasma IL-6 levels were markedly elevated in patients with alcoholic hepatitis when compared with all control groups (P less than 0.001). IL-6 levels were higher in patients who died (P = 0.04) and correlated with the features of severe disease including: increased grade of encephalopathy, increased neutrophil count, increased prothrombin ratio, hypotension, increased serum creatinine and increased serum bilirubin. Surprisingly, no correlation was found between levels of plasma IL-6 and plasma TNF-alpha or endotoxin, or the presence of infection; an inverse correlation was found between plasma IL-6 and serum globulins. These findings provide further evidence that the IL-6/TNF cytokine system is activated in severe alcoholic hepatitis and may mediate hepatic or extra-hepatic tissue damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044224      PMCID: PMC1535433     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

Authors:  J Deviere; J Content; C Denys; P Vandenbussche; L Schandene; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

2.  Response of serum interleukin-6 in patients undergoing elective surgery of varying severity.

Authors:  A M Cruickshank; W D Fraser; H J Burns; J Van Damme; A Shenkin
Journal:  Clin Sci (Lond)       Date:  1990-08       Impact factor: 6.124

3.  Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat.

Authors:  J V Castell; T Geiger; V Gross; T Andus; E Walter; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Biochem       Date:  1988-11-01

4.  Interleukin 6 is involved in interleukin 1-induced activities.

Authors:  M Helle; J P Brakenhoff; E R De Groot; L A Aarden
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

5.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

6.  Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis.

Authors:  A Theodossi; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

7.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Authors:  Y Fong; K J Tracey; L L Moldawer; D G Hesse; K B Manogue; J S Kenney; A T Lee; G C Kuo; A C Allison; S F Lowry
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

8.  The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

Authors:  A Waage; P Brandtzaeg; A Halstensen; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.

Authors:  V Lehmann; M A Freudenberg; C Galanos
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

10.  Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblasts.

Authors:  P B Sehgal; D C Helfgott; U Santhanam; S B Tatter; R H Clarick; J Ghrayeb; L T May
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  26 in total

Review 1.  The hepatorenal syndrome.

Authors:  L Dagher; K Moore
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 2.  Circulating cytokines as biomarkers of alcohol abuse and alcoholism.

Authors:  Rajeshwara N Achur; Willard M Freeman; Kent E Vrana
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

3.  Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.

Authors:  Valentina Medici; Janet M Peerson; Sally P Stabler; Samuel W French; Jesse F Gregory; Maria Catrina Virata; Antony Albanese; Christopher L Bowlus; Sridevi Devaraj; Edward A Panacek; Nazir Rahim; John R Richards; Lorenzo Rossaro; Charles H Halsted
Journal:  J Hepatol       Date:  2010-05-31       Impact factor: 25.083

4.  Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines.

Authors:  Vikrant Rachakonda; Charles Gabbert; Amit Raina; Huanan Li; Shahid Malik; James P DeLany; Jaideep Behari
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.455

5.  The acute phase protein response in patients receiving subcutaneous IL-6.

Authors:  R E Banks; M A Forbes; M Storr; J Higginson; D Thompson; J Raynes; J M Illingworth; T J Perren; P J Selby; J T Whicher
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  Post-operative circulating cytokine patterns--the influence of infection.

Authors:  M Kristiansson; M Soop; L Saraste; K G Sundqvist
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

Review 8.  New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments.

Authors:  Charles S Lieber
Journal:  Curr Gastroenterol Rep       Date:  2004-02

Review 9.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

10.  Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.

Authors:  Peter J McGuire; Hye-Seung Lee; Marshall L Summar
Journal:  J Pediatr       Date:  2013-09-29       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.